Glaucoma Archives - Page 2 of 7 - MPR


FDA to Review Bimatoprost SR Implant for IOP Reduction in Glaucoma, Ocular HTN

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for bimatoprost sustained-release (SR; Allergan), a first-in-class biodegradable implant, for the reduction of intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension. The NDA includes data from two phase 3 studies (NCT02250651, NCT02247804) that evaluated the efficacy…